Pharmaceuticals

In the last 48 hours

Class Attys Want $11.6M In Fees From $35M Teva Inhaler Deal Law36021:31 8-Jun-26

Incyte Acquires Vega In Hematology-Focused Diversification Plan Scrip Pharma Intelligence19:27 8-Jun-26

Roche signs $2.3bn blood cancer drug agreement with Nurix Therapeutics Pharmaceutical Technology17:51 8-Jun-26

Biogen's Base Is Declining — But 8 Pipeline Readouts Could Flip The Story Benzinga17:19 8-Jun-26

SK Biopharmaceuticals opens New Jersey hub for Korean biotech firms Investment Monitor14:06 8-Jun-26

Infant receives world's first gene therapy for WOREE syndrome News-Medical.Net13:26 8-Jun-26

Roche To Pay Nurix Up To $2.3B In Cancer Drug Deal Law36015:15 8-Jun-26

view more headlines

In the last 7 days

Gilead And Lakefront Acquire Ouro Medicines In $1.67 Bln Agreement; To Co-Develop Gamgertamig RTT News12:07 5-Jun-26

Novartis reports positive results from Phase III ALIGN trial for IgAN Clinical Trials Arena10:44 5-Jun-26

Uzbekistan can provide more incentives to Indian pharma firms, aims to become regional hub for… The Times of India06:25 7-Jun-26

Behind the headlines of ASCO 2026 FiercePharma15:16 5-Jun-26

Sanofi Eczema Drug Suits Consolidated, Sent To NJ Fed Court Law36022:38 5-Jun-26

As pro-life pressure ramps up on Trump, FDA is investigating safety of abortion pill: WSJ FiercePharma16:17 5-Jun-26

Roswell Park study tests new targeted AML combination Buffalo News, New York06:11 5-Jun-26

Supreme Court Reverses Federal Circuit in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.: A Unanimous Decision… JD Supra15:31 5-Jun-26

STAT Plus: Pharmalittle: We’re reading about Roche accusing U.S. of ‘blackmail,’ a ruling on… STAT14:22 5-Jun-26

Maharashtra FDA seizes medical devices, gloves worth ₹2.17 cr in crackdown on irregularities Hindustan Times14:22 5-Jun-26

Fierce Pharma Asia—China's biotech rise; ASCO highlights; Lilly pipeline deals FiercePharma13:34 5-Jun-26

Pharma is betting big on PD-1/VEGF bispecifics. But are companies chasing the wrong target? BioPharma Dive13:21 5-Jun-26

Biogen’s salanersen gets FDA Breakthrough Therapy Designation for SMA PMLiVE13:11 5-Jun-26

CVS Health Just Announced Fantastic News to Eli Lilly Stock Investors The Motley Fool11:05 5-Jun-26

CorrectSequence’s base-editing therapy shows preliminary success in sickle cell disease European Pharmaceutical Review10:43 5-Jun-26

Lilly and Novo now look beyond US for obesity drug growth The Hindu Business Line08:06 5-Jun-26

Alembic Pharma receives USFDA approval for Haloperidol tablets The Business Standard07:41 5-Jun-26

Japan becomes first overseas partner in US “Genesis Mission,” dubbed the AI Manhattan Project Asia Today05:38 5-Jun-26

UroGen Pharma, Teva End Patent Dispute Over Urinary Cancer Drug Bloomberg Law18:43 4-Jun-26

GSK Bets on Specialty Medicines to Drive Long-Term Revenue Growth Zacks16:32 3-Jun-26

Bull vs. Bear: The Quick Take on Viking Therapeutics Stock The Motley Fool11:55 3-Jun-26

Lupin Wins FDA Approval For Ranluspec Biosimilar To Lucentis RTT News04:09 5-Jun-26

AI Rivals OpenAI, Google Deepmind And Anthropic Unite On Bioweapon Prevention Benzinga21:45 4-Jun-26

Antibiotic Combo Approved for Multidrug-Resistant UTIs Medpage Today18:28 4-Jun-26

Aurobindo Pharma’s generic of rheumatoid arthritis drug secures U.S. FDA nod The Hindu17:52 4-Jun-26

view more headlines

In the last 14 days

This Emerging Risk Is Unlike Anything the Biotech Industry Has Ever Experienced The Motley Fool19:17 31-May-26

FDA Form 483 flags falsified records and live bird infestation at Dabur India OTC plant Manufacturing Chemist12:56 29-May-26

AstraZeneca’s ‘game changer’ cancer pill stuck in limbo The Independent08:24 27-May-26

New T-cell engager therapy shows effectiveness in advanced solid tumors News-Medical.Net05:46 1-Jun-26

Pfizer partners with Innovent for $10.5bn to advance ADC oncology medicines European Pharmaceutical Review11:20 29-May-26

CelLBxHealth shares jump 36% after master services agreement with AstraZeneca Proactive Investors (UK)09:03 29-May-26

France becomes first EU country to reimburse anti-obesity drugs The Connexion14:00 28-May-26

Wockhardt gets Cdsco nod for Zaynich antibiotic The Times of India07:23 28-May-26

Tata-backed MedTherapy claims car-T breakthrough with one-day production The Times of India16:07 27-May-26

Outlook moves toward potential US nod for thrice-snubbed eye drug with FDA appeal win FiercePharma13:31 27-May-26

Skymap Pharma to buy state-run Indian Medicines Pharma for Rs 121 crore The Times of India20:44 26-May-26

Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight loss The Times of India11:00 2-Jun-26

Wockhardt corrects after blockbuster run on antibiotic approval The Business Standard10:31 2-Jun-26

Legend Reports Positive Phase 1 Data For LB2102 In Treating Cancer, Disease Control Rates Reach 70% RTT News07:23 2-Jun-26

Pfizer Sues Alkem to Block Copies of Inlyta Kidney-Cancer Drug Bloomberg Law21:12 1-Jun-26

Lilly Engages Haisco In Five-Drug Collaboration Scrip Pharma Intelligence20:56 1-Jun-26

Wockhardt’s Novel Drug Zaynich To Hit US In 2026, EU Likely Next Year Scrip Pharma Intelligence19:34 1-Jun-26

These 8 Words From Eli Lilly's CEO Have Wall Street Turning Bullish The Motley Fool19:12 1-Jun-26

Merck exec says company is discussing use of Covid antiviral drug in Ebola response The Tribune, California18:30 1-Jun-26

CRISPR Therapeutics' Secret Weapon That Many Investors Are Overlooking The Motley Fool17:41 1-Jun-26

Abbott's CE Mark Win for Libre Duo Systems May Lift Its Stock Zacks15:55 1-Jun-26

Abbott Accused of Firing Manager for Reporting Kickback Schemes Bloomberg Law14:24 1-Jun-26

NEXT BIOMEDICAL taps Terumo Europe to distribute Nexsphere-F in EMEA markets Korea Biomedical Review07:14 1-Jun-26

China’s biotech ascent forces US industry to choose: Is the country an ally or an existential… Boston Globe16:50 31-May-26

Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More The Motley Fool20:01 30-May-26

view more headlines

About our Pharmaceuticals news

NewsNow aims to be the world's most accurate and comprehensive pharmaceutical news aggregator, bringing you the latest headlines from the best pharma sites and other key national and regional news sources. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication.

Publication filters

Sorry, no headlines or news topics were found. Please try different keywords.